Bio-Rad Laboratories (BIO) Gross Margin (2009 - 2026)

Bio-Rad Laboratories (BIO) has 18 years of Gross Margin data on file, last reported at 52.25% in Q1 2026.

• On a quarterly basis, Gross Margin fell 2.0% year-over-year to 52.25% in Q1 2026; TTM through Mar 2026 was 51.87%, a 161.0% decrease from a year earlier, with the FY2025 full-year figure at 51.87%, down 186.0% from the prior year.
• Gross Margin for Q1 2026 stood at 52.25%, up from 49.8% in the prior quarter.
• Over the last five years, Gross Margin for BIO reached as high as 57.51% in Q1 2022 and fell as low as 49.8% in Q4 2025.
• Historically, Gross Margin has averaged 53.67% across 5 years, with a median of 53.36% in 2024.
• Across the five-year window, Gross Margin jumped 240 bps in 2022 and sank 396 bps in 2023, its largest moves.
• Year by year, Gross Margin stood at 54.37% in 2022, then fell by 1 bps to 53.77% in 2023, then retreated by 5 bps to 51.24% in 2024, then fell by 3 bps to 49.8% in 2025, then gained by 5 bps to 52.25% in 2026.
• Per Business Quant data, the three most recent Gross Margin figures were 52.25% in Q1 2026, 49.8% in Q4 2025, and 52.59% in Q3 2025.